Support to the network of National Cancer Mission Hubs (NCMHs)
Quick Facts
Email me updates on this grant
Get notified about:
- Deadline changes
- New FAQs & guidance
- Call reopened
- Q&A webinars
We'll only email you about this specific grant. Unsubscribe anytime. No spam.
Ready to Apply?
Get a personalized assessment of your eligibility and application strategy
See in 5 min if you're eligible for Support to the network of National Cancer Mission Hubs (NCMHs) offering max €31.0M funding💰 Funding Details
Support to the network of National Cancer Mission Hubs (NCMHs)
Call at a glance
- Call Identifier: HORIZON-MISS-2025-02-CANCER-06
- Type of Action: HORIZON-CSA (Lump-Sum)
- Total EU Budget: €31 000 000 (one or more grants)
- Opening Date: 06 May 2025
- Deadline: 16 September 2025 – 17:00 (Brussels time)
- Single-stage submission
What is funded?
The grant finances coordination and support actions that:
1. Reinforce and operate the Network of National Cancer Mission Hubs (NCMHs) across all Member States and Associated Countries for the entire lifetime of the EU Cancer Mission and beyond.
2. Integrate Cancer Mission activities into national, regional and local ecosystems, aligning with Europe’s Beating Cancer Plan and your country’s cancer strategies/control plans.
3. Engage stakeholders & citizens in thematic and country-specific policy dialogues, annual citizen engagement activities, and joint events with other EU Missions.
4. Build sustainable national hubs able to attract philanthropic and private funding post-EU financing.
5. Coordinate knowledge exchange (training, best-practice sharing, methodology development) and disseminate results through annual conferences & policy reports.
Funding model – Lump Sum
- 100 % of eligible lump-sum amount is paid according to predefined project milestones/deliverables; no cost reporting required.
- Payment schedule is fixed in the Grant Agreement; careful planning of work packages and deliverables is therefore crucial.
Who should apply?
- Ministries or agencies in charge of health, research or cancer control.
- Universities, cancer institutes, patient organisations, regional authorities and innovation agencies experienced in mission-oriented R&I.
- Minimum eligibility: three legal entities from three different EU or Associated Countries. Given the policy-coordination nature, consortia typically exceed the minimum and include one entity per participating your country.
Indicative project duration
48–60 months, enabling two full years of post-ECHoS consolidation and ramp-up towards Mission mid-term review.
📊 At a Glance
Get Grant Updates
Get notified about:
- Deadline changes
- New FAQs & guidance
- Call reopened
- Q&A webinars
We'll only email you about this specific grant. Unsubscribe anytime. No spam.
🇪🇺 Strategic Advantages
EU-Wide Advantages & Opportunities for “Support to the Network of National Cancer Mission Hubs (NCMHs)”
Single Market Access
- 450+ million beneficiaries: Harmonised NCMH services allow equitable outreach to all citizens in the EU/EEA, enlarging recruitment pools for prevention campaigns, clinical trials, and citizen-science initiatives.
- Pan-EU patient pathways: Common screening and referral protocols reduce fragmentation, enabling smoother cross-border care and second-opinion flows.
- Economies of scale: Joint procurement (e.g. of digital engagement tools, communication materials) lowers unit costs and accelerates deployment across Member States.
Cross-Border Collaboration
- Fast-track knowledge transfer: The grant explicitly funds regular exchanges and joint activities between NCMHs, connecting >27 national ecosystems that would otherwise collaborate bilaterally at best.
- Shared infrastructures: Links to pan-European research infrastructures (BBMRI-ERIC, ECRIN, ELIXIR) give every hub access to biobanks, trial platforms and data services without duplicating investments.
- Mission-to-Mission synergies: Mandatory interaction with hubs from Climate, Ocean, Soil and Cities Missions opens new prevention angles (e.g., environmental carcinogens), multiplying impact.
EU Policy Alignment
- Europe’s Beating Cancer Plan: NCMHs become the national delivery mechanisms translating flagship EU actions (Tobacco-Free Generation, Cancer Screening Scheme, ECPDC) into local practice.
- European Health Union & EHDS (European Health Data Space): Coordinated citizen-centric data governance pilots showcase compliance, building trust in the upcoming legal framework.
- Digital Decade & Digital Europe: Integration with ECPDC nodes accelerates digital health literacy, AI-enabled screening and tele-oncology solutions.
- Green Deal co-benefits: By tackling pollution-related cancers, hubs contribute to Zero-Pollution targets and demonstrate health-environment nexus.
Regulatory Harmonisation
- GDPR-ready engagement templates: EU-level guidance reduces legal uncertainty when collecting patient-reported data or running citizen science activities.
- EU Clinical Trials Regulation (CTR): NCMHs can act as single national entry points helping SMEs and academia navigate the new CTIS system, boosting trial attractiveness.
- Coordinated HTA: Early involvement of joint EU Health Technology Assessment bodies streamlines market access strategies for innovative diagnostics and therapeutics tested within NCMH networks.
Innovation Ecosystem Access
- Top-tier R&I actors: Consortium members can seamlessly tap into Horizon Europe partnerships (Innovative Health Initiative, ERA4Health, Ring for Cancer Research) for co-development.
- Living labs & test beds: Collaboration with Digital Innovation Hubs and EIT Health nodes provides sandboxes for AI, mHealth, VR-based psycho-oncology, etc.
- Talent circulation: Mobility schemes (Marie Skłodowska-Curie, Erasmus+) facilitate secondments of clinicians, data scientists and citizen-engagement specialists among hubs.
Funding Synergies
- EU4Health & Cohesion Policy: Structural Funds can finance physical infrastructure upgrades identified by NCMHs, while EU4Health supports prevention roll-outs.
- Digital Europe Programme: Complements grant-funded activities by covering HPC/AI resources for large-scale data analytics.
- InvestEU & philanthropic leverage: The action must design sustainability models that crowd-in private and philanthropic capital; being EU-branded increases credibility and risk-sharing, unlocking blended finance.
Scale & Impact Potential
- From pilots to systemic change: Uniform methodologies enable rapid replication—e.g., a citizen engagement format validated in Portugal can be deployed in Poland within weeks.
- Pan-European evidence base: Annual NCMH reports feed a consolidated dataset for policy monitoring, giving the Commission unprecedented real-time insight into cancer control progress.
- Global standard-setter: Coordinated EU approach positions Europe as reference model for mission-oriented health policies, strengthening geopolitical influence in WHO/OECD forums.
Strategic Value of Operating at EU Scale
1. Critical mass: Aggregating national hubs provides statistical power for rare cancer research, impossible within single-country populations.
2. Unified voice: NCMHs act collectively when negotiating with industry or advocating policy changes, increasing bargaining power.
3. Risk diversification: Lump-sum model paired with multi-country consortium disperses financial and operational risks, enhancing project resilience.
4. Brand visibility: “EU Cancer Mission Hub” label elevates stakeholder engagement and media coverage, furthering citizen trust and political buy-in.
---
Actionable Take-Aways for Applicants
- Form tripartite consortia (public-private-civil society) in at least 15-20 Member/Associated States to maximise evaluation scores on impact and implementation.
- Embed work packages on EHDS compliance and philanthropy attraction to address sustainability criterion.
- Allocate budget for joint annual EU Cancer Mission Week (conference + citizen dialogues + brokerage events) to satisfy multiple scope bullets cost-efficiently.
- Map and cross-reference synergy funding (EU4Health, Digital Europe) already available in partner regions to demonstrate leverage potential.
🏷️ Keywords
Ready to Apply?
Get a personalized assessment of your eligibility and application strategy
See in 5 min if you're eligible for Support to the network of National Cancer Mission Hubs (NCMHs) offering max €31.0M funding